Literature DB >> 23453429

Sources of information and factual knowledge in Europeans with inflammatory bowel diseases: a cross-cultural comparison between German and Irish patients.

Irina Blumenstein1, Edel McDermott, Denise Keegan, Kathryn Byrne, Martha Ellison, Glen Doherty, Oliver Schröder, Hugh Mulcahy.   

Abstract

BACKGROUND: Disease related knowledge may be associated with quality of life, coping skills and medication adherence. However, little is known of cross-cultural variations regarding inflammatory bowel disease knowledge or sources of information and no study has assessed knowledge in diverse European IBD populations. AIM: To assess sources of information and patient knowledge in Irish and German inflammatory bowel disease patients.
METHODS: Three hundred and three disease, gender, age and education matched German and Irish patients completed a previously validated knowledge questionnaire. Additional data were collected on age, gender, education, disease type and duration, family history, smoking habits, medication use, previous surgery and quality of life.
RESULTS: German patients obtained knowledge from a wider range of sources than Irish patients (p<0.001), most notably from the internet (p<0.001), newspapers and magazines (p=0.002). Both cohorts answered a similar number of questions correctly (Irish, mean 4.4 questions (Standard deviation (S.D.) 2.4); German, mean 4.3 (S.D. 2.2); p=0.67). In addition, both nationalities answered "don't know" to a similar number of questions (Irish, mean 3.3 (S.D. 3.1); German, mean 2.7 (S.D. 2.8); p=0.12) while Irish patients answered slightly fewer questions wrongly (Irish, mean 2.4 (S.D. 1.8); German, mean 3.1 (S.D. 1.9); p=0.002). A multivariate analysis included only Crohn's disease, female gender, young age and higher educational status as being significantly and independently associated with knowledge.
CONCLUSIONS: Our data suggest few differences between German and Irish IBD patients, despite cultural and linguistic differences, with regard to disease related knowledge of IBD.
Copyright © 2013 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Crohn's disease;; Health related quality of life; Inflammatory bowel disease;; Patient knowledge;; Ulcerative colitis;

Mesh:

Year:  2013        PMID: 23453429     DOI: 10.1016/j.crohns.2013.01.006

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  5 in total

1.  Variable access to quality nutrition information regarding inflammatory bowel disease: a survey of patients and health professionals and objective examination of written information.

Authors:  Alexis C Prince; Arifa Moosa; Miranda C E Lomer; Dianne P Reidlinger; Kevin Whelan
Journal:  Health Expect       Date:  2014-06-17       Impact factor: 3.377

2.  Disease-Related Knowledge and Information Needs Among Inflammatory Bowel Disease Patients in Korea.

Authors:  Yang-Sook Yoo; Ok-Hee Cho; Kyeong-Sook Cha
Journal:  Gastroenterol Nurs       Date:  2015 Nov-Dec       Impact factor: 0.978

3.  Effectiveness of a decision aid for patients with depression: A randomized controlled trial.

Authors:  Lilisbeth Perestelo-Perez; Amado Rivero-Santana; Juan Antonio Sanchez-Afonso; Jeanette Perez-Ramos; Carmen Luisa Castellano-Fuentes; Karen Sepucha; Pedro Serrano-Aguilar
Journal:  Health Expect       Date:  2017-03-10       Impact factor: 3.377

4.  Daily life difficulties among patients with ulcerative colitis in Japan and the United Kingdom: A comparative study.

Authors:  Aki Kawakami; Makoto Tanaka; Kayoko Sakagami; Lee Meng Choong; Reiko Kunisaki; Shin Maeda; Ingvar Bjarnason; Hiroaki Ito; Bu'Hussain Hayee
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

5.  Treatment Adherence in Inflammatory Bowel Disease Patients from Argentina: A Multicenter Study.

Authors:  Juan Lasa; Gustavo Correa; Claudia Fuxman; Laura Garbi; Maria Eugenia Linares; Pablo Lubrano; Astrid Rausch; Martin Toro; Martin Yantorno; Ignacio Zubiaurre; Laurent Peyrin-Biroulet; Pablo Olivera
Journal:  Gastroenterol Res Pract       Date:  2020-01-17       Impact factor: 2.260

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.